The Tumor Suppressor CYLD: A Molecular Switchboard Controlled by Chemical Tags
A new review reveals how the tumor suppressor and deubiquitinating enzyme CYLD is switched on and off by phosphorylation, ubiquitination, ...
A new review reveals how the tumor suppressor and deubiquitinating enzyme CYLD is switched on and off by phosphorylation, ubiquitination, ...
A new review highlights how cell-free DNA methylation markers, shaped in part by hepatitis B virus-driven epigenetic changes, could transform ...
A new evolutionary analysis shows that NOTCH1 mutations flourish in normal esophageal tissue but epistatically suppress the later driver mutations, ...
Researchers at Tokushima University found that combined TP53 and CDKN2A mutations activate cGAS–STING-mediated antitumor immunity, delaying progression to invasive oral ...
Researchers have discovered that DNA methylation evicts the architectural protein CTCF from the HOXD locus, collapsing a chromatin loop that ...
A new review in Cancer Cell International details how the tumor suppressor RUNX3 regulates apoptosis, drug efflux, cell cycle control, ...
A new review argues that CRISPR-based DNA methylation editing can transform cancer epigenetics from a correlative science into a causal ...
In a groundbreaking discovery that could reshape the landscape of lymphoma treatment, Australian scientists have unveiled a critical cellular mechanism ...
In a groundbreaking study poised to reshape the landscape of precision oncology, researchers have conducted the largest pan-cancer analysis focusing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine